美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=KLONOPIN
符合检索条件的记录共10
1 页 当前第 1 页  返回检索页
1药品名称KLONOPIN
申请号017533产品号001
活性成分CLONAZEPAM市场状态处方药
剂型或给药途径TABLET;ORAL规格0.5MG
治疗等效代码AB参比药物
批准日期Approved Prior to Jan 1, 1982申请机构HOFFMANN LA ROCHE INC
2药品名称KLONOPIN
申请号017533产品号002
活性成分CLONAZEPAM市场状态处方药
剂型或给药途径TABLET;ORAL规格1MG
治疗等效代码AB参比药物
批准日期Approved Prior to Jan 1, 1982申请机构HOFFMANN LA ROCHE INC
3药品名称KLONOPIN
申请号017533产品号003
活性成分CLONAZEPAM市场状态处方药
剂型或给药途径TABLET;ORAL规格2MG
治疗等效代码AB参比药物
批准日期Approved Prior to Jan 1, 1982申请机构HOFFMANN LA ROCHE INC
4药品名称KLONOPIN
申请号017533产品号005
活性成分CLONAZEPAM市场状态停止上市
剂型或给药途径TABLET;ORAL规格0.125MG
治疗等效代码参比药物
批准日期1997/04/09申请机构HOFFMANN LA ROCHE INC
5药品名称KLONOPIN
申请号017533产品号006
活性成分CLONAZEPAM市场状态停止上市
剂型或给药途径TABLET;ORAL规格0.25MG
治疗等效代码参比药物
批准日期1997/04/09申请机构HOFFMANN LA ROCHE INC
6药品名称KLONOPIN RAPIDLY DISINTEGRATING
申请号020813产品号001
活性成分CLONAZEPAM市场状态停止上市
剂型或给药途径TABLET, ORALLY DISINTEGRATING;ORAL规格0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1997/12/23申请机构HOFFMANN LA ROCHE INC
7药品名称KLONOPIN RAPIDLY DISINTEGRATING
申请号020813产品号002
活性成分CLONAZEPAM市场状态停止上市
剂型或给药途径TABLET, ORALLY DISINTEGRATING;ORAL规格0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1997/12/23申请机构HOFFMANN LA ROCHE INC
8药品名称KLONOPIN RAPIDLY DISINTEGRATING
申请号020813产品号003
活性成分CLONAZEPAM市场状态停止上市
剂型或给药途径TABLET, ORALLY DISINTEGRATING;ORAL规格0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1997/12/23申请机构HOFFMANN LA ROCHE INC
9药品名称KLONOPIN RAPIDLY DISINTEGRATING
申请号020813产品号004
活性成分CLONAZEPAM市场状态停止上市
剂型或给药途径TABLET, ORALLY DISINTEGRATING;ORAL规格1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1997/12/23申请机构HOFFMANN LA ROCHE INC
10药品名称KLONOPIN RAPIDLY DISINTEGRATING
申请号020813产品号005
活性成分CLONAZEPAM市场状态停止上市
剂型或给药途径TABLET, ORALLY DISINTEGRATING;ORAL规格2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1997/12/23申请机构HOFFMANN LA ROCHE INC